ExodusPoint Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

ExodusPoint Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-32,171	Closed	-$57K	–	2440
2022 Q2	$57K	Sell	32,171 -1,987	-6%	-$4.46K	﹤0.01%	1791
2022 Q1	$103K	Sell	34,158 -128,721	-79%	-$344K	﹤0.01%	2003
2021 Q4	$606K	Buy	+162,879	New	+$953K	0.01%	1300
2021 Q2	–	Sell	-29,964	Closed	-$572K	–	2958
2021 Q1	$572K	Sell	29,964 -95,649	-76%	-$1.75M	0.01%	1252
2020 Q4	$2.2M	Buy	125,613 +93,190	+287%	+$1.12M	0.02%	504
2020 Q3	$345K	Buy	+32,423	New	+$333K	0.01%	1213

Other funds holding HGEN

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ExodusPoint Capital Management's HGEN Position: Q3 2022 in Review

ExodusPoint Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q3 2022, closing a stake of 32,171 shares — an estimated $57K sold.

ExodusPoint Capital Management first reported a position in HGEN in Q3 2020 and held it in 6 quarters. The position peaked at $2.2M in Q4 2020. 53 funds tracked by Wall St. Rank hold HGEN as of Q3 2022.

ExodusPoint Capital Management reported no remaining HUMANIGEN, INC. position as of Q3 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 32,171 HUMANIGEN, INC. shares in Q3 2022, an estimated $57K.
ExodusPoint Capital Management first reported a position in HUMANIGEN, INC. in Q3 2020 and held it in 6 quarters.
ExodusPoint Capital Management's HUMANIGEN, INC. position peaked at $2.2M in Q4 2020.
53 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2022.

Based on ExodusPoint Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.